2-[5-amino-3-(2-thienyl)-1H-pyrazol-1-yl]-5,6-dimethylpyrimidin-4(3H)-one, 95.0%, 500mg

4-DIFLUOROMETHOXY-3-METHOXYBENZALDEHYDE, 95.0%, 25g

Flacons à vis conique stérile, 2 ml, 200 pièce(s)

2,4-Difluorobenzylsulfonyl chloride, 97.0%, 250mg

((3aR,6R,6aR)-6-(Benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole-5,5-diyl)dimethanol, 95%, 100mg

5-bromo-3-chloro-8-methoxyisoquinoline, 250mg

6-Bromophthalazine-1,4-diol, 95.0%, 6g

4-Méthyl-3-nitroaniline, min.99%, pour la synthèse, 25 g, emballage en verre

2-Acetamido-5-bromothiazole, 95.0%, 25g

2,2,3,3-Tetrafluoropropyl Acrylate (stabilized with MEHQ)>98.0%(GC)5g

H-Sar-OMe.HCl, 98%, 10g

[2-(cyclopentylthio)ethyl]amine, 1g

3-(2,5-Dimethylphenyl)propionic acid, 1g